Leukemia & Lymphoma Society Seeks Applications for Translational Research

Funding Organization: 
Leukemia & Lymphoma Society
Type of Funding: 
Estimated Funding Amount: 
Up to $600k over 3 years
Proposal Deadline: 
Wednesday, November 15, 2017
Letter of Intent Deadline: 
Friday, September 29, 2017
Award/Eligibility Description: 

The Leukemia & Lymphoma Society is the world's largest voluntary health agency dedicated to funding blood cancer research, education, and patient services. Its mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

To advance these goals, the society's Translational Research Program was developed to encourage and provide early support for clinical research in leukemia, lymphoma, and myeloma focused on innovative approaches to treatment, diagnosis, and prevention. The program is designed to support new and innovative research that demonstrates high promise for translating basic biomedical knowledge to clinical application. Projects should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.

Grants are limited to a maximum of $600,000 over three years.

To be eligible, applicants must hold an MD, PhD, or equivalent degree and work in a domestic or foreign nonprofit organizations such as a university, college, hospital, or laboratory.